Moors & Cabot
NEO icon

Moors & Cabot’s NeoGenomics NEO Stock Holding History

Moors & Cabot’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$285K Sell
15,550
-200
-1% -$3.3K 0.01% 783
2026
Q2 		$230K Buy
15,750
+2,750
+21% +$26.5K 0.01% 854
2026
Q1 		$96.5K Sell
13,000
-2,500
-16% -$26.3K ﹤0.01% 902
2025
Q4 		$182K Buy
15,500
+1,750
+13% +$18.9K 0.01% 859
2025
Q3 		$106K Buy
13,750
+1,750
+15% +$12.3K ﹤0.01% 880
2025
Q2 		$87.7K Buy
12,000
+2,000
+20% +$16.1K ﹤0.01% 859
2025
Q1 		$94.9K Buy
+10,000
New +$125K ﹤0.01% 840

Other funds holding NEO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Moors & Cabot's NEO Position: Q3 2026 in Review

Moors & Cabot reduced its NeoGenomics (NEO) stake by 1.3% in Q3 2026, selling an estimated $3.3K and leaving 15,550 shares worth $285K. The position accounts for 0.01% of the portfolio, ranked #783.

Moors & Cabot first reported a position in NEO in Q1 2025 and has held it in 7 quarters since. 117 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Moors & Cabot held 15,550 shares of NeoGenomics worth $285K as of Q3 2026.
  • Moors & Cabot sold 200 NeoGenomics shares in Q3 2026, an estimated $3.3K.
  • NeoGenomics made up 0.01% of Moors & Cabot's portfolio in Q3 2026, its #783 holding.
  • Moors & Cabot first reported a position in NeoGenomics in Q1 2025 and has held it in 7 quarters since.
  • 117 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Moors & Cabot's 13F filing for Q3 2026, filed 6 Nov 2026.